What You Should Know:
- Miist Therapeutics, a pioneering company developing inhaled medicines with a focus on rapid drug delivery raises $7M ina seed funding round led by Refactor Capital with participation from 1517 Fund, Freeflow Ventures, and others,
- The investment will accelerate the development of Miist's innovative therapies for smoking addiction and migraine.
Fast-Acting Therapies for Smoking Addiction and Migraine
Miist's therapies address a significant unmet
Read More
70% of People with Diabetes Feel Stigma: Abbott Survey Reveals Challenges
What You Should Know:
- A recent survey and film conducted by Abbott reveals the significant impact of stigma and misconceptions on people living with diabetes.
- The survey, which polled over 2,600 people with diabetes across eight countries, including the United States, revealed that nearly 70% believe there is stigma associated with their condition.
Impact of Misconceptions and Stereotypes on People with Diabetes
People living with diabetes – which now includes
Read More
SimpliFed Raises $4M to Expand Virtual Maternal Healthcare Platform
What You Should Know:
- SimpliFed, a provider of virtual maternal healthcare, today announced a $4M funding round led by Morningside.
- The investment will support the company's expansion from a point solution focused on baby feeding to a comprehensive maternal care technology platform powered by its newly updated Maternal Health Operating System (mOS).
Improved Maternal Health Outcomes
SimpliFed partners with over 300 health systems, independent practices, and health
Read More
Vantive Launches as Independent Vital Organ Therapy Company
What You Should Know:
- Vantive, formerly known as Baxter Kidney Care, today announced its launch as a new standalone company focused on vital organ therapies.
- The formation follows the completion of its acquisition by funds managed by Carlyle (NASDAQ: CG) from Baxter International Inc. (NYSE: BAX). Building on a 70-year legacy of innovation in kidney care, Vantive is committed to extending lives and expanding possibilities for patients with kidney disease and other vital
Read More
Owkin Doses First Patient in Phase I Trial of AI-Optimized Cancer Therapy OKN4395
What You Should Know:
- Owkin, an AI-powered biotech company, today announced the dosing of the first patient in its Phase I clinical trial of OKN4395, a novel cancer therapy designed to restore immune function in patients with advanced solid tumors.
- OKN4395 represents a novel approach to cancer treatment by targeting multiple immunosuppressive pathways simultaneously.
OKN4395 Background
OKN4395 is a first-in-class asset that selectively inhibits three
Read More
Suki Secures Investment from Zoom Ventures for AI-Driven Clinical Asst.
What You Should Know:
- Suki, a provider of artificial intelligence (AI) technology for healthcare, announced a strategic investment from Zoom Ventures, the investment arm of Zoom Communications, Inc.
- the investment builds upon Suki's recent $70M Series D funding round and reinforces the company's commitment to transforming healthcare through AI-powered solutions.
Suki’s AI-Driven Clinical Assistant
Suki's AI-driven clinical assistant, Suki Assistant, is used by over 350
Read More
Samsung Medison Launches AI-Powered Ultrasound System, Z20
What You Should Know:
- Samsung Medison, a global leader in medical equipment, has unveiled its latest innovation in women's health: the Samsung Z20, a premium AI-powered ultrasound system designed for advanced OB-GYN applications.
- The Z20 made its U.S. debut at the Society for Maternal-Fetal Medicine (SMFM) 2025 conference in Denver, Colorado, showcasing its cutting-edge features and commitment to improving patient care.
Improving Diagnostic Accuracy
The Z20's advanced
Read More
Delfina Care Raises $17M to Expand AI-Powered Maternal Health
What You Should Know:
- Delfina Care, a healthcare technology company addressing the maternal health crisis raises $17M in Series A funding round led by U.S. Venture Partners (USVP) with included participation from ARTIS Ventures, Mayo Clinic, Tokio Marine Future Fund, Story Ventures, SemperVirens, Bread and Butter Ventures, Boutique Ventures, and Chelsea Clinton's Metrodora Ventures.
- The investment will fuel Delfina's growth and expansion, enabling the company to deliver its
Read More
OSE Immunotherapeutics & Scienta Lab Partner to Advance AI-Driven Drug Discovery
What You Should Know:
- OSE Immunotherapeutics SA, a biotechnology company focused on developing innovative immunotherapies, and Scienta Lab, a pioneer in AI-driven precision immunology is forming a strategic collaboration to leverage the power of artificial intelligence (AI) in the fight against inflammatory diseases.
- The partnership will harness Scienta Lab's advanced AI platform, EVA, to identify predictive biomarkers of efficacy for immunotherapies. EVA is a multimodal
Read More
Aetna Better Health Taps Twentyeight Health to Expand Access to Women’s Healthcare
What You Should Know:
- Twentyeight Health, a digital-first women's healthcare platform is teaming up with with Aetna Better Health of Illinois, a CVS Health company, to provide expanded access to reproductive and sexual healthcare services for Aetna Better Health members.
- The partnership allows Aetna Better Health members in Illinois to utilize Twentyeight Health's telehealth platform to connect with experienced healthcare providers online, receive prescriptions delivered to their
Read More
